Skip to content

The Effects of the Tri-Ka-Tuk Formula on Metabolomics and Proteomics Modifications and Safety in Healthy Participants in Order to Develop Medicine or Supplement

The Effects of the Tri-Ka-Tuk Formula on Metabolomics and Proteomics Modifications and Safety in Healthy Participants in Order to Develop Medicine or Supplement

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250924003
Enrollment
12
Registered
2025-09-24
Start date
2024-10-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The study enrolled twelve healthy volunteers. traditional medicine, untargeted metabolomics, proteomics, LC-MS, piperine, herbal supplementation

Interventions

Participants took one 500 mg capsule of TKT orally three times daily (before breakfast, lunch, and dinner) for a duration of 7 days. ,Participants took one 500 mg capsule of cornstarch orally three ti
Experimental Dietary Supplement,Placebo Comparator Dietary Supplement
Tri-Ka-Tuk (TKT) group,placebo group

Sponsors

Thailand Science Research and Innovation (TSRI)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 59 Years

Inclusion criteria

Inclusion criteria: (1) aged between 25 and 59 years, (2) included both male and female participants, (3) proficient in reading, writing, speaking, and listening in Thai, (4) no prior history of adverse reactions to any components of the Tri-Ka-Tuk formula, specifically ginger, pepper, long pepper, or corn, and (5) good general health as confirmed by a comprehensive physical examination and medical history assessment conducted by a qualified physician

Exclusion criteria

Exclusion criteria: (1) Presenting with fever exceeding 37.5 C (2) Current use of medications including rifampicin, theophylline, propranolol, or phenytoin (3) Pregnancy, lactation, or actively preparing for pregnancy (4) Current use of oral contraceptives (5) Habitual consumption of alcohol or tobacco products

Design outcomes

Primary

MeasureTime frame
Change in plasma biomedical characteristics Baseline and Day 7 Automated biochemical analyzer

Secondary

MeasureTime frame
Change in metabolomes and proteomes Baseline and Day 7 LC-MS

Countries

Thailand

Contacts

Public ContactPariyapat Singthong

Faculty of Thai Traditional and Alternative, Ubon Ratchathani Rajabhat University

pariyapat.s@ubru.ac.th0864882533

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026